Items where authors include "O'Brien, M.E."

Article

Shah, M.H., Lorigan, P., O'Brien, M.E. et al. (5 more authors) (2016) Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors. Investigational New Drugs, 34 (3). pp. 290-299. ISSN 0167-6997